AI Verdict
MSFT has stronger fundamentals based on our AI analysis.
NAMSW vs MSFT Fundamental Comparison
| Metric | NAMSW | MSFT |
|---|---|---|
| Revenue | $22.5M | $158.9B |
| Net Income | $-203.8M | $66.2B |
| Net Margin | -905.7% | 41.7% |
| ROE | -29.8% | 16.9% |
| ROA | -26.5% | 10.0% |
| Current Ratio | 7.88x | 1.39x |
| Debt/Equity | 0.00x | 0.10x |
| EPS | $-1.72 | $8.87 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NAMSW vs MSFT: Frequently Asked Questions
Is NAMSW or MSFT a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MSFT has stronger fundamentals. NAMSW is rated STRONG SELL (88% confidence) while MSFT is rated BUY (91% confidence). This is not investment advice.
How does NAMSW compare to MSFT fundamentally?
NewAmsterdam Pharma Co N.V. has ROE of -29.8% vs MICROSOFT CORP's 16.9%. Net margins are -905.7% vs 41.7% respectively.
Which stock pays higher dividends, NAMSW or MSFT?
NAMSW has a dividend yield of N/A or no dividend while MSFT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NAMSW or MSFT for long term?
For long-term investing, consider that NAMSW has STRONG SELL rating with 88% confidence, while MSFT has BUY rating with 91% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NAMSW vs MSFT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NAMSW vs MSFT, the AI consensus favors MSFT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.